BackLantern Pharma Overview

Lantern Pharma Current Cash

Lantern Pharma's current cash is $4.9M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$4.92M
↓ 22.89% YoYΔ $-1.46M vs prior year quarter

Peer average

Loading

Lantern Pharma Current Cash History

Loading

Lantern Pharma vs. peers: Current Cash Comparison

Loading

Lantern Pharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lantern Pharma (LTRN) FAQ

The latest current cash for LTRN is $4.9M as of March 2026. That compares with $6.4M in the prior-year period — down 22.9% year over year. Investors often review this figure alongside Lantern Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, LTRN's current cash moved from $6.4M to $4.9M — a 22.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lantern Pharma's operating scale or balance-sheet position.

A current cash figure of $4.9M for LTRN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LTRN's current cash ($4.9M), review year-over-year change from $6.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Lantern Pharma's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.